NYSE
WLKP
Last Price
US $21.70
KEY FIGURES
MKT CAP
$0.8B
EPS
TTM
$1.62
PEG
TTM
N/M
P/E
TTM
13.41x
P/S
TTM
0.63x
YIELD
8.69%
GROWTH
Revenue Y/Y
3.83%
(FY vs FY)
EBITDA Y/Y
Cash Flow (DCF)
Fair Value
Market $21.70
54.38%
Default assumptions
EBITDA Multiple
Fair Value
Market $21.70
265.39%
Default assumptions
Valuation
Financial
Performance
Financial stability - Cash flow debt coverage.
Westlake Chemical Partners LP cash flow to debt ratio of 70.17% indicates that the company generates enough cash to cover a substantial portion of its debt. This level indicates very strong financial health.
Financial risk - Healthy cash flow growth.
Westlake Chemical Partners LP's free cash flow has decreased -53.75% from $436.03M last year to $201.65M, signaling decreasing performance
Financial risk - Healthy debt to equity ratio.
Westlake Chemical Partners LP's debt to equity ratio is 1.58, which means that the company's assets are unhealthy financed, signaling financial risk. READ MORE: A ratio over 0.60 means the company finances its assets with debt, signaling financial risk. If ratio is negative, the company spent its own equity and risks bankruptcy
Financial risk - Healthy debt to equity ratio development.
Westlake Chemical Partners LP's debt has increased relative to shareholder equity from 0.77 last year to 1.58 today, signaling weakened financials
Financial stability - Net debt/EBITDA.
Westlake Chemical Partners LP has a net debt to EBITDA ratio of 0.79x, which is below the 3.00x threshold, indicating healthy leverage and financial stability
Financial stability - ICR.
Westlake Chemical Partners LP's interest coverage ratio of 10.34 indicates that earnings with good margin can cover interest payments on company debt
Financial risk - Profit margin growth.
Westlake Chemical Partners LP's profit margin has decreased (-15.07%) in the last year from 5.49% to 4.66%, signaling decreasing performance
Financial stability - Short term assets vs short term liabilities.
Westlake Chemical Partners LP's short-term assets of $143.51M exceed its short-term liabilities of $51.30M
Decreasing performance - ROA.
Westlake Chemical Partners LP's return on assets of 4.73% is lower than the 5.00% threshold, indicating inefficient asset utilization
Decreasing performance - Absolute return on equity.
Westlake Chemical Partners LP's return on equity of 13.12%, is lower than 15.00%, indicating bad performance
Increasing performance - Earnings quality.
Westlake Chemical Partners LP's operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation
Increasing performance - Earnings stability.
Westlake Chemical Partners LP had positive net income in 5.00 out of 5 years, indicating stable and consistent earnings
Increasing performance - Free cash flow.
Westlake Chemical Partners LP has positive free cash flow, indicating the company generates cash after capital expenditures
Increasing performance - FCF yield.
Westlake Chemical Partners LP has a free cash flow yield of 26.37%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Decreasing performance - Healthy earnings growth.
Westlake Chemical Partners LP's yearly earnings has decreased -21.95% since last year from $62.39M to $48.70M, signaling decreasing performance
Increasing performance - Healthy revenue growth.
Westlake Chemical Partners LP's yearly revenue has increased 2.71% since last year from $1.14G to $1.17G, signaling increasing performance
Increasing performance - ROIC.
ROIC 30.30% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.
Decreasing performance - 3-year revenue CAGR.
Westlake Chemical Partners LP's 3-year revenue CAGR of -9.86% is negative, indicating declining revenue over the past 3 years
Increasing performance - Revenue consistency.
Westlake Chemical Partners LP had revenue growth in 3.00 out of 5 years, indicating consistent revenue performance
Increasing performance - ROE consistency.
Westlake Chemical Partners LP had positive ROE in 5.00 out of 5 years, indicating consistent and reliable returns on equity
Undervalued - DCF valuation.
Westlake Chemical Partners LP is undervalued relative to its fair value price of 33.50 based on Discounted Cash Flow model
Undervalued - Earnings yield.
Westlake Chemical Partners LP has an earnings yield of 7.46%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings
Undervalued - EBITDA valuation.
Westlake Chemical Partners LP is undervalued relative to its fair value price of 79.29 based on EBITDA multiple model
Undervalued - EV/EBITDA.
Westlake Chemical Partners LP has an EV/EBITDA ratio of 2.49x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings
Overvalued - PEG ratio value.
Westlake Chemical Partners LP has a PEG-ratio over 1 which is considered overvalued
Undervalued - P/B ratio.
Westlake Chemical Partners LP has a price-to-book ratio of 1.00x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Undervalued - P/S ratio.
Westlake Chemical Partners LP has a price-to-sales ratio of 0.63x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
13.12%
Return on equity
ROIC: 30.30%
Valuation History
13.3X
Price to Earnings
EV/EBITDA: 2.3X
Cash flow
Profit margin
-0.30%
(FY vs FY)
Cash flow Y/Y
-9.73%
(FY vs FY)
Base valuations use default assumptions. Customize in the Valuator.